Procedure‐related readmissions following endoscopic retrograde cholangiopancreatography in a liver transplant cohort

Abstract Background and Aim Data on post‐endoscopic retrograde cholangiopancreatography (ERCP) adverse events and readmission rates in liver transplantation (LT) patients remain scarce. This study determined the 30‐day procedure‐related readmission rate following ERCP in an LT cohort at an Australia...

Full description

Saved in:
Bibliographic Details
Main Authors: Jennifer Gu, Leonardo Zorron Cheng Tao Pu, Jonathan Ng, Kim H Be, Rhys Vaughan, Sujievvan Chandran, Marios Efthymiou
Format: Article
Language:English
Published: Wiley 2024-10-01
Series:JGH Open
Subjects:
Online Access:https://doi.org/10.1002/jgh3.70008
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850201740246253568
author Jennifer Gu
Leonardo Zorron Cheng Tao Pu
Jonathan Ng
Kim H Be
Rhys Vaughan
Sujievvan Chandran
Marios Efthymiou
author_facet Jennifer Gu
Leonardo Zorron Cheng Tao Pu
Jonathan Ng
Kim H Be
Rhys Vaughan
Sujievvan Chandran
Marios Efthymiou
author_sort Jennifer Gu
collection DOAJ
description Abstract Background and Aim Data on post‐endoscopic retrograde cholangiopancreatography (ERCP) adverse events and readmission rates in liver transplantation (LT) patients remain scarce. This study determined the 30‐day procedure‐related readmission rate following ERCP in an LT cohort at an Australian tertiary academic center. Methods All unplanned readmissions within 30 days following ERCP in orthotopic LT patients between December 2012 and August 2021 were retrospectively identified. Demographic data, procedure variables, and readmission characteristics were also collected. Results Forty‐five procedure‐related readmissions were identified (3.3%) from a total of 1369 ERCP procedures. This included 33 cases of cholangitis (2.4%), 7 cases of nonspecific abdominal pain (0.5%), 5 cases of mild post‐ERCP pancreatitis (0.5%), and 3 cases of bleeding (0.2%). No procedure‐related mortality was observed. Conclusion The procedure‐related readmission rate following ERCP in this LT cohort was 3.3%, which is likely lower than comparable studies carried out on the overall population.
format Article
id doaj-art-6a1ef2e4bf6e42d0a320d4cc8d567377
institution OA Journals
issn 2397-9070
language English
publishDate 2024-10-01
publisher Wiley
record_format Article
series JGH Open
spelling doaj-art-6a1ef2e4bf6e42d0a320d4cc8d5673772025-08-20T02:11:57ZengWileyJGH Open2397-90702024-10-01810n/an/a10.1002/jgh3.70008Procedure‐related readmissions following endoscopic retrograde cholangiopancreatography in a liver transplant cohortJennifer Gu0Leonardo Zorron Cheng Tao Pu1Jonathan Ng2Kim H Be3Rhys Vaughan4Sujievvan Chandran5Marios Efthymiou6Medicine, Dentistry and Health Sciences University of Melbourne Parkville Victoria AustraliaDepartment of Gastroenterology and Hepatology Austin Health Melbourne Victoria AustraliaDepartment of Gastroenterology and Hepatology Austin Health Melbourne Victoria AustraliaDepartment of Gastroenterology and Hepatology Austin Health Melbourne Victoria AustraliaMedicine, Dentistry and Health Sciences University of Melbourne Parkville Victoria AustraliaMedicine, Dentistry and Health Sciences University of Melbourne Parkville Victoria AustraliaMedicine, Dentistry and Health Sciences University of Melbourne Parkville Victoria AustraliaAbstract Background and Aim Data on post‐endoscopic retrograde cholangiopancreatography (ERCP) adverse events and readmission rates in liver transplantation (LT) patients remain scarce. This study determined the 30‐day procedure‐related readmission rate following ERCP in an LT cohort at an Australian tertiary academic center. Methods All unplanned readmissions within 30 days following ERCP in orthotopic LT patients between December 2012 and August 2021 were retrospectively identified. Demographic data, procedure variables, and readmission characteristics were also collected. Results Forty‐five procedure‐related readmissions were identified (3.3%) from a total of 1369 ERCP procedures. This included 33 cases of cholangitis (2.4%), 7 cases of nonspecific abdominal pain (0.5%), 5 cases of mild post‐ERCP pancreatitis (0.5%), and 3 cases of bleeding (0.2%). No procedure‐related mortality was observed. Conclusion The procedure‐related readmission rate following ERCP in this LT cohort was 3.3%, which is likely lower than comparable studies carried out on the overall population.https://doi.org/10.1002/jgh3.70008adverse eventscomplicationsendoscopic retrograde cholangiopancreatographyliver transplantationreadmissions
spellingShingle Jennifer Gu
Leonardo Zorron Cheng Tao Pu
Jonathan Ng
Kim H Be
Rhys Vaughan
Sujievvan Chandran
Marios Efthymiou
Procedure‐related readmissions following endoscopic retrograde cholangiopancreatography in a liver transplant cohort
JGH Open
adverse events
complications
endoscopic retrograde cholangiopancreatography
liver transplantation
readmissions
title Procedure‐related readmissions following endoscopic retrograde cholangiopancreatography in a liver transplant cohort
title_full Procedure‐related readmissions following endoscopic retrograde cholangiopancreatography in a liver transplant cohort
title_fullStr Procedure‐related readmissions following endoscopic retrograde cholangiopancreatography in a liver transplant cohort
title_full_unstemmed Procedure‐related readmissions following endoscopic retrograde cholangiopancreatography in a liver transplant cohort
title_short Procedure‐related readmissions following endoscopic retrograde cholangiopancreatography in a liver transplant cohort
title_sort procedure related readmissions following endoscopic retrograde cholangiopancreatography in a liver transplant cohort
topic adverse events
complications
endoscopic retrograde cholangiopancreatography
liver transplantation
readmissions
url https://doi.org/10.1002/jgh3.70008
work_keys_str_mv AT jennifergu procedurerelatedreadmissionsfollowingendoscopicretrogradecholangiopancreatographyinalivertransplantcohort
AT leonardozorronchengtaopu procedurerelatedreadmissionsfollowingendoscopicretrogradecholangiopancreatographyinalivertransplantcohort
AT jonathanng procedurerelatedreadmissionsfollowingendoscopicretrogradecholangiopancreatographyinalivertransplantcohort
AT kimhbe procedurerelatedreadmissionsfollowingendoscopicretrogradecholangiopancreatographyinalivertransplantcohort
AT rhysvaughan procedurerelatedreadmissionsfollowingendoscopicretrogradecholangiopancreatographyinalivertransplantcohort
AT sujievvanchandran procedurerelatedreadmissionsfollowingendoscopicretrogradecholangiopancreatographyinalivertransplantcohort
AT mariosefthymiou procedurerelatedreadmissionsfollowingendoscopicretrogradecholangiopancreatographyinalivertransplantcohort